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OBJECTIVE — Toinvestigatesprint-trainingeffectsonmusclemetabolismduringexercisein
subjects with (type 1 diabetic group) and without (control group) type 1 diabetes.
RESEARCH DESIGN AND METHODS — Eight subjects with type 1 diabetes and
seven control subjects, matched for age, BMI, and maximum oxygen uptake (V ˙ O2peak), under-
took 7 weeks of sprint training. Pretraining, subjects cycled to exhaustion at 130% V ˙ O2peak.
Posttrainingsubjectsperformedanidenticaltest.Vastuslateralisbiopsiesatrestandimmediately
after exercise were assayed for metabolites, high-energy phosphates, and enzymes. Arterialized
venous blood drawn at rest and after exercise was analyzed for lactate and [H
]. Respiratory
measures were obtained on separate days during identical tests and during submaximal tests
before and after training.
RESULTS — Pretraining,maximalrestingactivitiesofhexokinase,citratesynthase,andpyru-
vate dehydrogenase did not differ between groups. Muscle lactate accumulation with exercise
washigherintype1diabeticthannondiabeticsubjectsandcorrespondedtoindexesofglycemia
(A1C, fasting plasma glucose); however, glycogenolytic and glycolytic rates were similar. Post-
training, at rest, hexokinase activity increased in type 1 diabetic subjects; in both groups, citrate
synthase activity increased and pyruvate dehydrogenase activity decreased; during submaximal
exercise, fat oxidation was higher; and during intense exercise, peak ventilation and carbon
dioxideoutput,plasmalactateand[H
],musclelactate,glycogenolyticandglycolyticrates,and
ATP degradation were lower in both groups.
CONCLUSIONS — High-intensity exercise training was well tolerated, reduced metabolic
destabilization (of lactate, H
, glycogenolysis/glycolysis, and ATP) during intense exercise, and
enhancedmuscleoxidativemetabolisminyoungadultswithtype1diabetes.Thelattermayhave
clinically important health beneﬁts.
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epeated bouts of brief, high-
intensity exercise are characterized
not only by marked metabolic and
ionic destabilization in exercising muscle
but also by progressively increasing aero-
bic ATP generation, such that by just the
third 30-s bout, 63% of ATP is generated
oxidatively (1). It is therefore not entirely
surprising that high-intensity (sprint) ex-
ercisetrainingresultsinoxidativeadapta-
tions in muscle. These adaptations
includereducedglycogenolysisandlower
accumulation ofmuscle lactate and hydro-
gen ions during high-intensity matched-
work exercise (2); increased activity of
oxidative enzymes such as citrate synthase
(3–5), cytochrome c oxidase (6), and -
hydroxyacyl-CoA dehydrogenase (-HAD)
(4); reduced ATP degradation during in-
tense exercise (2,5,7); and increased peak
oxygen consumption (V ˙ O2peak) (2–5,8).
Theonlystudy(9)toexaminemuscle
metabolism during exercise in patients
withtype1diabetes(comparedwithcon-
trol subjects) reported lower muscle oxi-
dative capacity and higher glycolytic ﬂux
and acidosis. No studies have directly in-
vestigated the longitudinal effects of exer-
cise training on muscle metabolism in
these patients. Thus, while young adults
with type 1 diabetes undertake exercise
and sports of various intensities, includ-
ing high-intensity exercise and training,
clinicianshavelittleevidenceuponwhich
toprovideadvice.Basedonadaptationsin
healthy subjects, we hypothesized that
high-intensity exercise training in young
adults with type 1 diabetes would in-
crease muscle oxidative capacity, attenu-
ate glycogenolytic rate, and reduce
myocellular metabolic destabilization
during high-intensity exercise.
RESEARCH DESIGN AND
METHODS— Eight subjects (ﬁve
men and three women) with type 1 dia-
betes (type 1 diabetic group) ([means 
SD] duration of diabetes 7.1  4.0 years;
A1C 8.6  0.8%) and seven subjects
(four men and three women) without di-
abetes (control group) (A1C 5.3  0.3%)
were recruited concurrently over 3 years.
Control subjects closely matched those
with diabetes for age (type 1 diabetic
group aged 25  4 years; control group
aged 25  4 years), BMI (type 1 diabetic
group 25.4  3.2 kg/m
2; control group
23.8  5.0 kg/m
2), and V ˙ O2peak (type 1
diabeticgroup3.300.97l/min;control
group 3.17  0.79 l/min), as detailed in a
separate report on this study (10). Poten-
tialtype1diabeticsubjectswereexcluded
forproteinuria,microalbuminuria,prolif-
erative retinopathy (10 microaneu-
rysms in the last year), and autonomic or
peripheralneuropathies.Controlsubjects
had no family history of metabolic disor-
ders. No subject smoked or took regular
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were sedentary (i.e., no regular exercise;
type 1 diabetic group, n  1; control
group, n  2) or were recreationally ac-
tive. Each subject provided voluntary
writtenconsent.Thisstudywasapproved
bytheinstitutionalhumanresearchethics
committees.
Testing was conducted after over-
night fasting. Subjects in the type 1 dia-
betic group reduced their evening insulin
dose by 1–2 units to prevent hypoglyce-
mia on the morning of the tests and de-
layed their morning insulin dose until
after testing. All subjects replicated their
pretraining dietary intake (photocopied
record) for the 2 days before posttesting.
Subjects abstained from alcohol con-
sumptionandvigorousexercisefor2days
before each test. Subjects in the type 1
diabetic group recorded daily insulin
dose for 2 weeks before and throughout
training. Seven subjects used a combined
protocolofshort-actingandbasalinsulin,
and one subject used 15/85 neutral/
isophane mixed insulin.
Exercise testing
Incremental test. As previously de-
scribedforthesesubjects(10),asubmaxi-
mal, then incremental (10 W/30 s), cycle
test to fatigue was conducted before (2
days after a familiarization trial) and after
training on an electronically braked er-
gometer (Ergoline 800s; Mijnhardt, the
Netherlands). Steady-state V ˙ O2, V ˙ CO2,
and respiratory exchange ratio were de-
terminedduringtheﬁnalminuteof4-min
workrates of 60, 90, 120, and 150 W.
Three female subjects (TID group, n  2;
control group, n  1) could not complete
150 W before training; thus, an interme-
diate load of 110 W was substituted for
the purpose of generating an individual
regression equation of V ˙ O2 versus power.
Peak V ˙ O2 (V ˙ O2peak) was determined, and
the power output required to elicit 130%
V ˙ O2peak was calculated.
Constantloadsprinttests. Pretraining,
following an identical test on a separate
day (used to collect respiratory data), a
sprint test to exhaustion was conducted
on the cycle ergometer. After a 3-min
warm-up at 20 W, subjects pedaled at a
poweroutputequivalentto130%V ˙ O2peak
until exhaustion. Muscle and blood were
sampled. Posttraining, a test was con-
ducted at the same power output and for
the same duration (i.e., identical work,
with blood and muscle sampling times
matched to pretraining). On a separate
day, respiratory data were collected (time
matched with the pretraining respiratory
test).Expiredvolumewasdeterminedus-
ing a pneumotachometer (Hans Ru-
dolph), and expired gas fractions were
determined by O2 and CO2 analyzers
(Ametek; Thermox Instruments, Pitts-
burgh, PA), which were calibrated imme-
diately before and after each test.
Muscle sampling and analyses
Percutaneous muscle biopsies with suc-
tion were performed at rest and immedi-
ately after exercise (on the cycle
ergometer). Muscle samples (type 1 dia-
betic group, n  7; control group, n  6)
were immediately immersed in liquid ni-
trogenthendividedandstoredat80°C.
For enzymes, frozen wet muscle (30
mg) was homogenized in a medium com-
prising 50 mmol/l Tris-HCl, 20 mmol/l
EGTA, 25 mmol/l NaF, and 1 mmol/l
benzamidine, pH 7.4. Activities of hexo-
kinase (11), the activated form of pyru-
vate dehydrogenase (PDHa), and citrate
synthase (12) were determined spectro-
photometrically (Cary3; Varian, Mul-
grave, Victoria, Australia) at 30°C in the
assay media for each enzyme and ex-
pressed relative to the respective pre- or
posttraining peak total creatine (TCr)
content as millimoles per minute per ki-
logramofdrymass.Formetabolites,mus-
cle was weighed, freeze dried, reweighed,
dissected free of connective tissue and
blood, powdered, and extracted. Extracts
wereanalyzedforATP,PCr,creatine,glu-
cose, glycogen, glycolytic intermediates,
and lactate on a luminescence spectrom-
eter (Aminco Bowman Series 2; SLM In-
struments, Urbana, IL) as previously
described (2). Metabolites (except glyco-
gen, glucose, pyruvate, and lactate) in
pre- and posttraining samples were ex-
pressed relative to the peak TCr obtained
before and after training, respectively, as
millimoles per kilogram of dry mass. The
rate of glycogenolysis in muscle was cal-
culatedas[(G1-PG6-PF6-P)
0.5(LacPyr)]/timeins;andtherate
ofglycolysisas0.5(LacPyr)/timein
seconds and expressed as millimoles per
kilogram of dry mass per second, where
G1-Pisglucose1-phosphate,G6-Pisglu-
cose 6-phosphate, F6-P is fructose
6-phosphate, Lac is lactate, and Pyr is
pyruvate.
Blood sampling and analyses
Arterialized blood was sampled from a
dorsal hand vein at rest in the ﬁnal sec-
onds of exercise and during an hour of
recovery. As previously described for this
study, A1C (13), catecholamines, blood
gases, hemoglobin, hematocrit, plasma
sodium, potassium, and glucose, gluca-
gon, and insulin levels were determined
(10). pH was determined in duplicate im-
mediately by blood gas analysis (Corning
865; Chiron Diagnostics) and plasma
[H
] calculated. The remaining blood
was centrifuged, and 250 	l of plasma
wasmixedwith500	l0.6mol/lperchlo-
ric acid, centrifuged, the supernatant re-
moved, and stored at 20°C until
analysis.Plasmalactateconcentrationwas
determined in triplicate as previously de-
scribed (2).
Exercise training
Subjects undertook 7 weeks of super-
vised, progressive high-intensity cycling
training, thrice weekly, as previously de-
scribed(2,8,10,13).Eachtrainingsession
comprised 4–10 30-s “all out” sprints on
an ergometer (Monark 668; Varberg,
Sweden), with each sprint separated by a
3- to 4-min passive rest. The number of
sprint bouts per session was increased
from four in week 1 to six in week 2,
eight in week 3, and 10 in weeks 4–7; the
rest interval was reduced from 4 to 3 min
in weeks 5–7 of training.
Statistics
Data were analyzed using t tests for base-
line variables and insulin dosage data and
repeated-measures ANOVA for muscle,
blood, and respiratory measures (within-
subject factors: training status  sample
time;between-subjectfactor:group;SPSS
10.0 for Windows). The Wilks’ 
 multi-
variate adjustment was used for blood
data. Signiﬁcant F ratios for blood data
were further examined using a post hoc
contrast technique. Data are expressed as
means  SE.
RESULTS
Performance
Power output in the constant-load tests
did not differ between groups (type 1 di-
abeticgroup,34041W;controlgroup,
350  39 W; P  0.86). Pretraining, in
both groups, time to fatigue did not differ
between the respiratory (65  4s )a n d
blood and muscle (70  5s ;P  0.14)
tests.
Daily insulin dosage
The daily insulin dose in the type 1 dia-
betic group (52.4  3.8 units/day) was
not altered by training (51.2  4.6 units/
day; P  0.66).
High-intensity exercise and type 1 diabetes
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During submaximal exercise posttrain-
ing, the respiratory exchange ratio was
lower (P  0.05), with no group differ-
ences(P0.95)(60W:pretraining,type
1 diabetic group 0.88  0.02 and control
group 0.90  0.03; posttraining, type 1
diabetic group 0.86  0.02 and control
group 0.86  0.03; 90 W: pretraining,
type 1 diabetic group 0.97  0.02 and
control group 0.94  0.03; posttraining,
type 1 diabetic group 0.92  0.02 and
control group 0.91  0.02; and 120 W:
pretraining, type 1 diabetic group 1.01 
0.04 and control group 0.98  0.03;
posttraining, type 1 diabetic group
0.98  0.03 and control group 0.94 
0.03).
Ventilation and plasma acidosis
Peak V ˙ O2 did not differ between the con-
stant-load (3.29  0.21 l/min) and incre-
mental tests (3.24  0.22 l/min; P 
0.56). Pretraining in the constant-load
test, the groups did not differ on any re-
spiratory variable (Table 1). Posttraining,
during identical exercise, estimated to
elicit 125  0.03% of pretraining V ˙ O2peak
(P  0.06), peak expired ventilation and
carbon dioxide output were reduced,
with no group differences. Plasma lactate
and [H
] were less elevated posttraining,
withnogroupdifferences(Fig.1AandB).
Muscle metabolism
Peak TCr did not differ with training
(117.6  3.5 vs. 119.5  3.4 mmol/kg
dm, pre- vs. posttraining, respectively;
P  0.35) or between groups (P  0.63).
Muscle free glucose content rose with ex-
ercise (Table 2), was unaffected by train-
ing, and was higher in the type 1 diabetic
group. Glycogen content was reduced
37  3% by exercise pretraining (Table
2), with no group differences. Posttrain-
ing, glycogen degradation tended to be
less (P  0.07). Glycolytic intermediate
(glucose 1-phosphate, glucose 6-phos-
phate, and fructose 6-phosphate) content
increased with exercise (Table 2), with no
difference after training or between
groups. Muscle pyruvate content in-
creased approximately sixfold with in-
tense exercise and was nearly halved after
training (Table 2), with a tendency for a
greater effect in the type 1 diabetic group
(P0.06).Musclelactateduringexercise
was higher in the type 1 diabetic group
pretraining (Table 2), and lactate accu-
mulation was strongly correlated with in-
dexes of glycemia (A1C and fasting
plasma glucose; both r
2  0.45, P 
0.01). Posttraining, lactate during exer-
cise was reduced, more so in the type 1
diabeticgroup,andtherewasnorelation-
ship between lactate accumulation and
A1C (r
2  0.02, P  0.96) or fasting
plasma glucose (r
2  0.16, P  0.60).
Estimated rates of glycogenolysis and gly-
colysis during exercise pretraining did
not differ between groups and were
20% lower posttraining (Fig. 1C). Mus-
cle ATP content was reduced with exer-
cise before training (P  0.001; type 1
diabetic group, rest 22.8  1.0 mmol/kg
dm, exercise 16.1  0.6 mmol/kg dm;
control group, rest 22.9  0.8 mmol/kg
dm, exercise 17.5  0.5 mmol/kg dm).
Posttraining, ATP degradation during ex-
ercise was attenuated (P  0.01; type 1
diabetic group, rest 21.3  0.5 mmol/kg
dm, exercise 19.5  1.0 mmol/kg dm;
control group, rest 20.6  0.7 mmol/kg
dm, exercise 17.5  1.0 mmol/kg dm)
more so in the type 1 diabetic group (P 
0.05).
Muscle enzyme activity
Pretraining, resting activities of hexoki-
nase,PDHa(Table2),andcitratesynthase
(Fig. 1D) did not differ between groups
nor did the hexokinase–to–citrate syn-
thase ratio. Posttraining, hexokinase ac-
tivity increased in the type 1 diabetic
group only, whereas citrate synthase ac-
tivity increased in both groups. Conse-
quently, the hexokinase–to–citrate
synthase ratio was increased in the type 1
diabetic group and reduced in the control
group (P  0.01; data not shown). For
both hexokinase and citrate synthase, en-
zyme activity was reduced with exercise
inthecontrolgroupbutunchangedinthe
type1diabeticgroup.Posttraining,PDHa
activity at rest was reduced; however,
there was no difference in PDHa immedi-
ately after exercise, and there were no
group differences.
CONCLUSIONS — The key ﬁndings
in this study were that high-intensity ex-
ercise training increased activity of citrate
synthase and reduced activity of PDHa at
rest; increased fat oxidation during sub-
maximal exercise; and during intense ex-
ercise, reduced ventilation and carbon
dioxideoutput,loweredplasmaandmus-
cle lactate accumulation, and lowered the
glycogenolytic and glycolytic rates, and
attenuated ATP degradation in young
adults with type 1 diabetes. Together,
these ﬁndings demonstrate that high-
intensitytrainingincreasedmuscleoxida-
tive capacity and reduced myocellular
metabolic destabilization and glycolytic
rate during intense exercise in type 1
diabetes.
Before training, muscle lactate accu-
mulationwashigherinthetype1diabetes
than the control group and was positively
correlated with indexes of glycemia. The
data may suggest lower muscle lactate
transportand/orPDHaactivityinthetype
1 diabetic group. However, PDHa did not
differ between groups. The only previous
study to examine muscle PDHa in pa-
Table 1—Respiratory data during the pre- and posttraining respiratory tests conducted at
130% pretraining V ˙ O2peak
Variable Pretraining Posttraining
V ˙ Epeak (l/min)*
Type 1 diabetic group 96.1  10.3 79.5  7.0
Control group 104.6  10.4 94.3  8.1
V ˙ O2peak (l/min)*
Type 1 diabetic group 3.44  0.33 3.14  0.27
Control group 3.12  0.28 3.03  0.35
Mean V ˙ O2 (l/min)
Type 1 diabetic group 2.49  0.21 2.33  0.18
Control group 2.32  0.23 2.35  0.23
V ˙ CO2peak
(l/min)†
Type 1 diabetic group 3.52  0.42 3.01  0.30
Control group 3.47  0.42 3.20  0.38
V ˙ E/V ˙ CO2
Type 1 diabetic group 28.0  1.1 26.9  1.3
Control group 30.7  1.6 30.4  1.8
Data are means  SE. Type 1 diabetic group, n  8; control group, n  7. V ˙ Epeak, peak expired ventilation,
BTPS; V ˙ O2peak, peak oxygen uptake, STPD; V ˙ CO2peak, peak carbon dioxide output, STPD; VE/V ˙ CO2, peak
ventilatory equivalent for carbon dioxide. *P  0.05; †P  0.01 pretraining vs. posttraining.
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no difference at rest compared with con-
trol subjects (14). Thus, although specu-
lative, it is possible that our type 1
diabetic group had lower muscle lactate
transportduringintenseexercisethanthe
control group. While no study has exam-
ined muscle lactate transport in type 1
diabetes, the muscle lactate transporter
content was reduced, and muscle lactate
higher, in patients with type 2 diabetic
compared with control subjects (15). The
strong association between muscle lactate
accumulation and glycemic indexes be-
fore training in the present study may re-
ﬂect a degree of lactate-induced insulin
resistance (16), or it is possible that mild
insulin deﬁciency or hyperglycemia may
affect lactate transport; however, this re-
mains to be tested.
The similar glycolytic rate during ex-
ercise in both groups in the present study
isconsistentwithﬁndingsinratswithand
without streptozotocin-induced diabetes
duringintenseisometriccontraction(17).
However, our data contrast with the
higher glycolytic rate (and lower oxida-
tive capacity) demonstrated with
31P–
magnetic resonance spectroscopy in the
only other study to investigate muscle
metabolism during exercise in patients
with type 1 diabetes versus control sub-
jects (9). The divergent ﬁndings in the
two studies may be due to differing nutri-
tional and insulin status and/or to within-
study differences in aerobic ﬁtness. In
contrast to the present study, Crowther et
al.’s (9) subjects had eaten and adminis-
tered insulin before exercise and were not
matched for V ˙ CO2peak with control sub-
jects. Further, the divergence may be
partly explained by the differing nature of
muscle contraction utilized (high-
frequencydynamicversusisometricexer-
cise, in which blood ﬂow is effectively
occluded).
After training, hexokinase activity in-
creased, and while citrate synthase activ-
ity also increased, the hexokinase–to–
citrate synthase ratio was increased in the
type 1 diabetic group. Theoretically, this
couldfavorglycolysisoveroxidationdur-
ing exercise after training; however, this
was not evident and there was actually a
20% reduction in the glycolytic rate (in
both groups), consistent with more ATP
beinggeneratedoxidatively.Anincreased
hexokinase–to–citrate synthase ratio is
suggested to be an expression of insulin
resistance in type 2 diabetes (18). In type
Figure1—AlldataaremeansSE.AandB:Plasmalactateandhydrogenionconcentrationsatrest,intheﬁnalsecondsofexercise(u),andduring
1 h of recovery in the group with type 1 diabetes (triangles) and the nondiabetic control group (circles), before (white symbols) and after (black
symbols) training. A: Plasma lactate concentration: a, main effects of time, P  0.001; b, training status, P  0.05; c, training status-by-time
interaction, P  0.05, pre-  posttraining. *P  0.05; **P  0.01; ***P  0.001. There were no signiﬁcant interaction effects for group: training
status-by-group, P  0.27; time-by-group, P  0.50; or training status-by-time-by-group, P  0.75. B: Hydrogen ion concentration: a, main effects
of time, P  0.001; b, training status, P  0.001; c, training status-by-time interaction, P  0.05, pre-  posttraining. **P  0.01; ***P  0.001.
There were no signiﬁcant interaction effects for training status-by-group, P  0.28; time-by-group, P  0.44; or training status-by-time-by-group,
P  0.32. ‚, type 1 diabetes pretraining; Œ, type 1 diabetes posttraining; E, control pretraining; F, control posttraining. C: Estimated rates of
glycogenolysis (total histogram) and glycolysis (hatched bar): both, d, main effect of training status, P  0.01, pre-  posttraining. D: Citrate
synthase activity (maximal in vitro). R, rest; Ex, end-exercise. d, main effect of training status, P  0.01, post-  pretraining; e, time-by-group
interaction, P  0.05, type 1 diabetes unchanged, control reduced with exercise. T1D, type 1 diabetic group; CON, control group.
High-intensity exercise and type 1 diabetes
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mon and insulin action is inversely re-
lated to A1C (19). A1C was unchanged
after training in the present study (pre-
training 8.6%, posttraining 8.1%, P 
0.09) (13); however, we did not measure
insulin sensitivity. Future studies investi-
gatingeffectsofhigh-intensitytrainingon
insulin sensitivity would be of interest.
During submaximal exercise after
training, muscle fat oxidation was greater
and carbohydrate oxidation less (as esti-
mated by the respiratory exchange ratio).
This typical “glycogen-sparing” effect of
endurance training has recently been
demonstrated after sprint training (4),
and our study extends this ﬁnding to in-
clude those with diabetes. Interestingly,
higher basal and insulin-stimulated fat
oxidation in patients with type 1 diabetes
compared with control subjects is associ-
ated with insulin resistance and manifests
metabolic inﬂexibility (20). However,
discussing a similar paradox, Kelley and
Mandarino (21) suggest that muscle lipid
handling should be interpreted relative to
oxidative enzyme capacity. The type 1 di-
abetes and control groups adapted simi-
larly to training, i.e., higher fat oxidation
during submaximal exercise and also
higher oxidative enzyme capacity. Addi-
tionally, there was no difference in glyco-
genolysisduringintenseexercisebetween
thegroups,whichsuggeststhatthetype1
diabetic group was as “metabolically ﬂex-
ible” (i.e., able to switch to greater carbo-
hydrate oxidation) (21) as the control
group.
During intense exercise after train-
ing, reduced metabolic destabilization
was evident (i.e., less increase in venti-
lation, V ˙ O2, plasma lactate and [H
],
muscle pyruvate and lactate, and less
ATP degradation; the glycogenolytic
and glycolytic rates were lower; and ci-
trate synthase activity increased in both
groups).Theseadaptationsreﬂectanin-
crease in leg muscle oxidative metabo-
lism after training. This is supported by
the increased V ˙ O2peak during incremen-
tal exercise after training in these sub-
jects (10). The results from the present
study are consistent with our previous
ﬁndings with sprint training in healthy
men (2).
In the present study, PDHa was re-
ducedatrestafterexercisetraining.PDHa
regulates pyruvate entry into the mito-
chondrion, thus being a key determinant
oftheamountoflactateaccumulationand
oxidative pyruvate metabolism. In ro-
dents, PDHa is inhibited by pyruvate de-
hydrogenase kinase, which is increased
by greater fat oxidation (22). Endurance-
trainedratshadlowermusclePDHacom-
pared with sedentary controls, likely due
to their higher activities of -hydroxya-
cyl-CoA dehydrogenase (a -oxidation
enzyme) and pyruvate dehydrogenase ki-
nase(23).Thisexplanationforlowerrest-
ing PDHa is plausible in the present
study, as it has been shown that sprint
training increases -hydroxyacyl-CoA
dehydrogenase (4). Since signiﬁcant fat
oxidation may occur during brief intense
exercise (24), it is possible that a higher
proportion of ATP was derived oxida-
tively from intramuscular fat after train-
ing. Also, although PDHa during exercise
did not differ after training, the lower rate
of glycogenolysis would likely permit a
higher proportion of pyruvate to be oxi-
dized, as we previously speculated (2),
which is consistent with lower lactate ac-
cumulation and attenuated ATP degrada-
tion after training.
In summary, the major difference
before training was higher muscle lac-
tate accumulation during intense exer-
cise in the type 1 diabetic group. Since
glycolytic rates and PDHa activity were
similar between the groups, this may
have been due to lower muscle lactate
transport. The key metabolic adapta-
tions to high-intensity exercise training
in both groups show that the glycolytic
rate and metabolic destabilization were
reduced and citrate synthase activity in-
creased. These adaptations strongly
suggest that muscle oxidative metabo-
lism was increased during intense exer-
cise after high-intensity training in
young adults with type 1 diabetes. Im-
portantly, high-intensity training was
Table 2—Muscle metabolites and enzyme activity
Type 1 diabetic group Control group
Rest Exercise Rest Exercise
Glycogen (glucosyl units)*
Pretraining 491  50 306  37 526  53 347  60
Posttraining 499  61 366  63 537  49 399  39
Glucose 1-phosphate*
Pretraining 0.1  0.0 0.8  0.2 0.1  0.0 0.9  0.2
Posttraining 0.1  0.0 0.8  0.2 0.1  0.0 0.6  0.1
Glucose*†
Pretraining 3.8  0.7 4.9  0.6 1.8  0.4 3.5  0.6
Posttraining 2.9  0.3 6.2  1.1 1.3  0.1 3.2  0.3
Glucose 6-phosphate*
Pretraining 1.5  0.3 23.3  1.8 1.4  0.22 22.2  2.7
Posttraining 1.5  0.2 20.1  2.2 1.2  0.2 19.4  1.8
Fructose 6-phosphate*
Pretraining 0.2  0.0 3.5  0.2 0.2  0.0 3.2  0.4
Posttraining 0.2  0.0 3.1  0.3 0.2  0.0 3.2  0.4
Pyruvate*‡§
Pretraining 0.2  0.0 0.9  0.2 0.1  0.0 0.6  0.0
Posttraining 0.1  0.0 0.4  0.1 0.2  0.0 0.6  0.1
Lactate*¶#**
Pretraining 3.4  0.3 114.8  4.3 4.2  0.7 88.6  7.0
Posttraining 4.0  0.6 80.0  7.2 3.9  0.5 78.3  4.7
Hexokinase††‡‡
Pretraining 8.9  0.5 8.5  0.4 9.0  0.6 6.6  0.6
Posttraining 12.9  0.7 12.3  0.4 9.5  0.6 7.3  0.6
Pyruvate dehydrogenase a*§§
Pretraining 0.8  0.1 1.9  0.3 1.0  0.2 2.1  0.3
Posttraining 0.6  0.1 1.7  0.2 0.5  0.1 1.7  0.2
Data are means  SE. Type 1 diabetic group, n  7; Control group, n  6. Units for muscle metabolites,
mmol/kg dm; units for enzyme activity, mmol   min
1   kg dm
1.* P  0.001, main effect of time, exercise
 rest (except for glycogen, which is rest  exercise); †P  0.01, Type 1 diabetic  Control group; ‡P 
0.05, main effect of training status; §P  0.05, training status-by-time interaction; P  0.01, main effect of
training status; ¶P  0.001, training status-by-time interaction; #P  0.05, time-by-group interaction;
**P  0.05, training status-by-time-by-group interaction; ††P  0.001, time-by-group interaction: T1D
group unchanged, CON group reduced with exercise; ‡‡P  0.01, training status-by-group interaction:
Type 1 diabetic  Control; §§P  0.05, training status at rest, pre-  posttraining.
Harmer and Associates
DIABETES CARE, VOLUME 31, NUMBER 11, NOVEMBER 2008 2101well-tolerated and did not have any ev-
ident adverse effects in our patients,
even though they were in moderate to
poor metabolic control. Increased skel-
etal muscle oxidative capacity is a desir-
able health outcome, particularly for
those with diabetes. The oxidative ad-
aptations to high-intensity exercise
training may confer clinically important
health beneﬁts in young patients with
type 1 diabetes; however, this remains
to be established.
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